Repurposing of gastric cancer drugs against COVID-19

Corona Virus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a global pandemic. Additionally, the SARS-CoV-2 infection in the patients of Gastric Cancer (GC; the third leading cause of death in the world) pose a great challenge for the health...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonkar, Charu, Doharey, Pawan Kumar, Rathore, Anuranjan Singh, Singh, Vishal, Kashyap, Dharmendra, Sahoo, Amaresh Kumar, Mittal, Nitish, Sharma, Bechan, Jha, Hem Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420180/
https://www.ncbi.nlm.nih.gov/pubmed/34537409
http://dx.doi.org/10.1016/j.compbiomed.2021.104826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420180/
https://www.ncbi.nlm.nih.gov/pubmed/34537409
http://dx.doi.org/10.1016/j.compbiomed.2021.104826

Ejemplares similares